Viatris has initiated a nationwide recall of Xanax XR (alprazolam extended-release) tablets due to a manufacturing issue.
The recall affects 3-milligram tablets packaged in 60-count bottles under lot number 8177156, with an expiration date of Feb. 28, 2027, according to an FDA enforcement report.
The FDA classified the recall as Class II, indicating the product may cause temporary or medically reversible adverse health effects.
The company said the recall was initiated March 17 and stems from failed dissolution specifications, which could affect how the drug releases in the body.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
